Patents by Inventor Mark Ebden

Mark Ebden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
    Patent number: 8106063
    Abstract: A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: January 31, 2012
    Assignee: AstraZeneca AB
    Inventors: Mark Ebden, Premji Meghani, Colin Bennion, Anthony Ronald Cook, Roger Victor Bonnert
  • Compounds 679
    Patent number: 7964616
    Abstract: The invention provides compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy, wherein R1, R2, R3 and n are as defined in the specification
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: June 21, 2011
    Assignee: AstraZeneca AB
    Inventors: Mark Ebden, Simon David Guile
  • Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
    Publication number: 20100063079
    Abstract: A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
    Type: Application
    Filed: July 24, 2009
    Publication date: March 11, 2010
    Inventors: MARK EBDEN, PREMJI MEGHANI, COLIN BENNION, ANTHONY RONALD COOK, ROGER VICTOR BONNERT
  • Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
    Patent number: 7582644
    Abstract: A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: September 1, 2009
    Assignee: AstraZeneca AB
    Inventors: Mark Ebden, Premji Meghani, Colin Bennion, Anthony Ronald Cook, Roger Victor Bonnert
  • Novel Compounds 679
    Publication number: 20080234319
    Abstract: The invention provides compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy, wherein R1, R2, R3 and n are as defined in the specification
    Type: Application
    Filed: March 21, 2008
    Publication date: September 25, 2008
    Inventors: Simon David Guile, Mark Ebden
  • Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
    Publication number: 20060025432
    Abstract: A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
    Type: Application
    Filed: July 23, 2003
    Publication date: February 2, 2006
    Inventors: Mark Ebden, Premji Meghani, Colin Bennion, Anthony Cook, Roger Bonnert
  • Pyrimidine derivatives as modulators of chemokine receptor activity
    Publication number: 20060004030
    Abstract: Compounds of formula (1), pharmaceutically acceptable salts, solvates and in vivo hydrolysable esters thereof, have activity as pharmaceuticals, in particular as modulators of chemokine receptor (especially CXCR2) activity, and may be in the treatment (therapeutic or prophylactic) of conditions/diseases in human and non-human animals which are exacerbated or caused by excessive or unregulated production of chemokines.
    Type: Application
    Filed: August 20, 2003
    Publication date: January 5, 2006
    Inventors: Mark Ebden, Premji Meghani, Anthony Cook, John Steele, Lal Lashkar Cheema